GALLI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 574
EU - Europa 333
AS - Asia 291
SA - Sud America 64
AF - Africa 51
Totale 1.313
Nazione #
US - Stati Uniti d'America 555
RU - Federazione Russa 189
SG - Singapore 149
IT - Italia 56
BR - Brasile 54
CN - Cina 40
CI - Costa d'Avorio 34
VN - Vietnam 33
BD - Bangladesh 24
IE - Irlanda 17
GB - Regno Unito 14
FR - Francia 13
CA - Canada 11
KR - Corea 11
NG - Nigeria 11
IN - India 9
HK - Hong Kong 6
NL - Olanda 6
AR - Argentina 5
CZ - Repubblica Ceca 5
DE - Germania 5
FI - Finlandia 5
IQ - Iraq 5
JP - Giappone 5
PL - Polonia 5
ES - Italia 4
MX - Messico 4
SE - Svezia 4
CH - Svizzera 3
SN - Senegal 3
HR - Croazia 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
VE - Venezuela 2
ZA - Sudafrica 2
AT - Austria 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
MV - Maldive 1
MY - Malesia 1
PR - Porto Rico 1
RW - Ruanda 1
SV - El Salvador 1
TR - Turchia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 1.313
Città #
Dallas 127
Singapore 108
Moscow 103
Santa Clara 95
Ashburn 44
San Jose 40
Abidjan 34
Los Angeles 33
Beijing 20
Dublin 17
New York 16
Chandler 14
Chicago 14
Ho Chi Minh City 14
Lauterbourg 12
Rende 12
Seoul 11
Buffalo 10
São Paulo 9
Abuja 8
Hanoi 8
Boston 7
Brooklyn 6
Civitanova Marche 6
Hong Kong 6
Montreal 6
Reggio Emilia 6
Boardman 5
London 5
Orem 5
Tokyo 5
Cambridge 4
Catania 4
Council Bluffs 4
Lawrence 4
San Francisco 4
Stockholm 4
Warsaw 4
Andover 3
Dakar 3
Denver 3
Jacksonville 3
Poplar 3
Tremestieri Etneo 3
Turku 3
Atlanta 2
Bastiglia 2
Bismarck 2
Brasília 2
Chennai 2
Columbus 2
Des Moines 2
Greenville 2
Guarujá 2
Johannesburg 2
Kochi 2
Manchester 2
Norfolk 2
Nuremberg 2
Port Harcourt 2
Prague 2
Rome 2
Scarsdale 2
Toronto 2
Zagreb 2
Zurich 2
Abington 1
Ahmedabad 1
Alvorada 1
Amman 1
Amsterdam 1
Ankara 1
Arcoverde 1
Arraial do Cabo 1
Arroio Grande 1
Baghdad 1
Belo Horizonte 1
Bernareggio 1
Bexley 1
Boa Esperança 1
Bofete 1
Bologna 1
Boydton 1
Bremen 1
Budapest 1
Bắc Giang 1
Cajazeiras 1
Caracas 1
Caserta 1
Castanhal 1
Changsha 1
Cleveland 1
Colognola ai Colli 1
Copenhagen 1
Cranston 1
Crateús 1
Cuiabá 1
Cumberland 1
Curitiba 1
Da Nang 1
Totale 931
Nome #
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 156
Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: A phase III, open-label, randomized trial 132
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 116
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study 112
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial 99
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 96
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 86
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 85
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 74
Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis 72
Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients 71
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 66
Weight gain: A possible side effect of all antiretrovirals 64
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting 53
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 52
Totale 1.334
Categoria #
all - tutte 4.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.031


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202218 1 3 0 0 3 0 3 1 1 0 0 6
2022/202351 4 2 2 5 5 7 0 8 14 0 1 3
2023/202422 1 8 1 0 0 3 0 1 0 0 8 0
2024/2025295 0 22 9 7 98 43 9 5 18 28 34 22
2025/2026931 45 30 147 84 152 226 66 19 32 64 49 17
Totale 1.334